Deep Learning for the Detection of Breast Cancers on Chest Computed Tomography [0.03%]
胸部CT肺癌检测的深度学习方法研究
Jieun Koh,Youngno Yoon,Sungwon Kim et al.
Jieun Koh et al.
Background: Incidental breast cancers can be detected on chest computed tomography (CT) scans. With the use of deep learning, the sensitivity of incidental breast cancer detection on chest CT would improve. This study aim...
Management of Breast Cancer Patients During the Coronavirus Disease 2019 Pandemic: The Experience From the Epicenter of China, Wuhan [0.03%]
新冠病毒肺炎疫情期间我国疫情中心武汉市乳腺癌患者的诊治和管理经验
Jun Zhou,Yuyin Liu,Ming Xu et al.
Jun Zhou et al.
Background: The coronavirus disease 2019 pandemic is a global public health event. Wuhan used to be the epicenter of China and finally controlled the outbreak through city lockdown and many other policies. However, the pa...
Human Papillomavirus (HPV) Detection by Chromogenic In Situ Hybridization (CISH) and p16 Immunohistochemistry (IHC) in Breast Intraductal Papilloma and Breast Carcinoma [0.03%]
人乳头瘤病毒（HPV）在乳腺导管内乳头状瘤和乳腺癌中的原位杂交及p16免疫组化检测
Hua Guo,Juan P Idrovo,Jin Cao et al.
Hua Guo et al.
Purpose: This study explored human papillomavirus (HPV) amplification in breast benign and malignant lesions by chromogenic in situ hybridization (CISH) and the concordance of p16 expression by immunohistochemistry. ...
Dietary Insulin Index and Insulin Load in Relation to Breast Cancer: Findings from a Case-Control Study [0.03%]
饮食胰岛素指数和胰岛素负荷与乳腺癌的关系：一项病例对照研究的发现
Fatemeh Sheikhhossein,Sakineh Shab-Bidar,Mohammad Reza Amini et al.
Fatemeh Sheikhhossein et al.
Background: No data are available on the association between dietary insulin index (DII) and dietary insulin load (DIL) and the risk of breast cancer (BC). ...
A 10-Gene Signature for Predicting the Response to Neoadjuvant Trastuzumab Therapy in HER2-Positive Breast Cancer [0.03%]
用于预测HER2阳性乳腺癌新辅助曲妥珠单抗治疗反应的10基因标志物
Luyao Jia,Yuwei Ling,Kaifu Li et al.
Luyao Jia et al.
Background and purpose: Dual-target therapy may increase the incidence of adverse events and cause economic burden to patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer. It is necessary t...
Comment on: "Oncologic Safety of Autologous Fat Grafting in Breast Reconstruction" [0.03%]
关于“乳房重建自体脂肪注射移植的肿瘤安全性”的几点评论
Andrea Lisa,Agnese Losurdo,Alberto Testori et al.
Andrea Lisa et al.
Charles L Shapiro
Charles L Shapiro
Bone-modifying agents (BMAs) are mainstays in breast cancer and prevent and treat osteoporosis in early-stage disease and reduce skeletal metastases complications in advanced disease. There is some evidence to support that BMA also prevents...
Meta-Analysis of Breast Cancer Risk in Levonorgestrel-Releasing Intrauterine System Users [0.03%]
左炔诺孕酮宫内节育系统使用者的乳腺癌风险meta分析研究
Fabio R Silva,Antonio Jose Grande,Ana Cristina Lacerda Macedo et al.
Fabio R Silva et al.
To map and assess evidence regarding use of the levonorgestrel-releasing intrauterine system (LNG-IUS) and its association with breast cancer, we conducted a systematic review and meta-analysis. A search strategy was developed using the ter...
Introduction to Special Issue [0.03%]
特刊介绍
Kari Wisinski,Ruth O&#x;Regan
Kari Wisinski
Concurrent Radiation and Modern Systemic Therapies for Breast Cancer: An Ever-Expanding Frontier [0.03%]
乳腺癌的同期放化疗与现代系统性治疗：前景无量的新领域
Jacob S Witt,Kari B Wisinski,Bethany M Anderson
Jacob S Witt
Radiotherapy is a critical tool for reducing locoregional recurrence, extending survival, and palliating symptoms in patients with breast cancer. With an ever-expanding armamentarium of systemic agents available, and an increasing trend tow...